Inhibikase Therapeutics, Inc.
← Back to IKT Overview

Inhibikase Therapeutics, Inc. (IKT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.96

Financial Fundamentals

IKTQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-03-31-103.95
2017-12-31572.33
2018-03-31-154.40
2018-12-31-20.20
2019-03-31-11.66
2019-06-30-8.64
2019-09-30-16.70
2019-12-31-47.09
2020-03-31-36.99
2020-06-30-48.00
2020-09-30-30.26
2020-12-31-11.83
2021-03-31-5.73
2021-06-30-3.25
2021-09-30-2.67
2021-12-31-1.84
2022-03-31-2.01
2022-06-30-1.01
2022-09-30-1.28
2022-12-31-0.74
2023-03-31-1.01
2023-06-30-0.82
2023-09-30-0.40
2023-12-31-0.47
2024-03-31-0.74
2024-06-30-0.47
2024-09-30-0.50
2024-12-31-4.65
2025-03-31-3.58
2025-06-30-4.43
2025-09-30-3.06
2025-12-31-3.96

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.